Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Founder Chairman & CEO at Lauren Sciences LLC
Susan Rosenbaum, J.D., is visionary, strategic biotech entrepreneur, executive. Founder, Chairman, CEO of Lauren Sciences LLC, New York biotech committed to development of its novel V-Smart® platform to create robust pipeline of transformative V-Smart® Nanomedicines, consisting of CNS-active drugs that normally do not cross BBB. Just some applications include PD, AD, ALS, GBM, Neuro-HIV, NPC. Lauren Sciences laboratories, research team are located at Ben-Gurion University, Israel, where V-Smart® technology was invented. V-Smart® breakthrough innovation solves greatest medical challenge in brain disease treatment – non-invasive targeted delivery of therapeutics to the brain. V-Smart® Nanomedicines encapsulate therapeutic agents, “macro” target brain and cross BBB, “micro” target and deliver to specific sites, cells in brain, selectively release at target sites, are administered systemically, uniquely solve challenge that most therapeutic agents, including biologicals, with potential to treat or cure brain diseases, do not cross BBB. Lauren Sciences has 10 foundation grant awards, 6 posters, 22 presentations, 18 published papers, 6 pipeline products, 10 patent families. Ms. Rosenbaum was founder of Maya Sciences LLC, with its novel Phase 1-ready cancer drug, MY-101, law and investment banking firms; has been member of board of directors for private, public companies; is national, international author, lecturer.